This bill establishes a national public awareness campaign, the SCREEN for Type 1 Diabetes Act, to promote the detection, screening, and management of type 1 diabetes among the public and healthcare providers.
Kim Schrier
Representative
WA-8
This bill, the SCREEN for Type 1 Diabetes Act of 2026, mandates the creation of a national public awareness campaign to promote the detection, screening, and management of type 1 diabetes. The campaign will utilize evidence-based materials and public service announcements targeted at both healthcare providers and the general public. It also authorizes funding for grants to support local efforts in increasing screening rates, particularly in highly affected communities.
SCREEN for Type 1 Diabetes Act Authorizes $25 Million for National Awareness and Early Detection Campaign Through 2031
The SCREEN for Type 1 Diabetes Act of 2026 is a targeted push to move the needle on early diagnosis for a condition that often catches families completely off guard. Starting in 2027, the bill authorizes $5 million annually for five years to fund a massive public awareness campaign led by the CDC. The goal is simple: get the word out about warning signs and screening before a medical emergency happens. For a parent or an adult suddenly feeling ‘off,’ this could mean the difference between a routine doctor’s visit and a life-threatening trip to the ICU.
A Toolkit for the Warning Signs
Under Section 2, the Secretary of Health and Human Services is tasked with building a digital and physical library of resources that explain the ‘red flags’ of Type 1 diabetes. This isn't just about brochures in a waiting room; the bill specifically mandates public service announcements across social media, internet platforms, and even through ‘trusted figures’ to reach people where they actually spend their time. For a busy office worker or a student, seeing a relatable ad about symptoms like extreme thirst or unexplained fatigue could be the prompt they need to ask for a simple blood test. The bill also requires these materials to be culturally and linguistically tailored, specifically focusing on communities that have seen the sharpest rise in cases over the last five years.
From Classrooms to Clinics
One of the most practical shifts in this bill is where the information goes. Section 2 requires the campaign to push data directly into elementary and secondary schools, as well as colleges. Since Type 1 often manifests in childhood or young adulthood, giving teachers and school nurses the latest evidence-based screening info means they can spot symptoms in a student before a crisis occurs. For healthcare providers in community clinics or pediatric offices, the bill ensures they receive updated management and detection protocols, effectively closing the gap between specialized research and your local family doctor.
Local Boots on the Ground
The bill doesn’t just keep the money in Washington; it requires the government to hand out grants to non-profits and local Tribal, state, and local health departments. These groups are expected to create localized strategies—like hosting screening events or distributing info on where to get tested in your specific neighborhood. While the $5 million annual price tag is relatively small in federal terms, the success of the program will depend on how well the CDC picks its partners. The bill includes a built-in accountability check, requiring a report to Congress within a year to see if these ads and grants are actually resulting in more people getting screened and diagnosed safely.